US · PG · HOUSEHOLD & PERSONAL PRODUCTS
The Procter & Gamble Company (PG) intrinsic value and stock valuation
$169.37as of 2026-11-21 · Mkt cap 348.95B
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
The Procter & Gamble Company DCF and intrinsic value
InvestorsCraft values PG with the Chepakovich two-stage DCF model — currently rated overvalued. How the model works · Run your own DCF prefilled from PG’s statements →
The Procter & Gamble Company Graham Number
Graham Number: $57.93d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →
How the business is doing
Fiscal 2012–2026, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
- Costco Wholesale Corporation (COST) $1,102.15
- The Coca-Cola Company (KO) $96.99
- Philip Morris International Inc. (PM) $184.09
- Unilever PLC (UL) $63.82
- Colgate-Palmolive Company (CL) $98.71
- Kenvue Inc. (KVUE) $19.31
- Kimberly-Clark Corporation (KMB) $106.38
- The Clorox Company (CLX) $104.73
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue | $87B | $84.3B | $84B | $82B | $80.2B |
| Operating income | $19.7B | $20.5B | $18.5B | $18.1B | $17.8B |
| Net income | $16B | $16B | $14.9B | $14.7B | $14.7B |
| EPSd | $6.62M | $6.51M | $6.02M | $5.9M | $5.81M |
| Operating cash flow | $20.3B | $17.8B | $19.8B | $16.8B | $16.7B |
| Capital expenditure | -$-4.41B | -$-3.77B | -$-3.32B | -$-3.06B | -$-3.16B |
| Free cash flow | $15.9B | $14B | $16.5B | $13.8B | $13.6B |
| Total assets | $126.5B | $125.2B | $122.4B | $120.8B | $117.2B |
| Total debt | $35B | $35.5B | $33.4B | $35.4B | $32.3B |
| Net debt | $25.1B | $25.9B | $23.9B | $27.2B | $25.1B |
| Total equity | $54.5B | $52.3B | $50.6B | $47.1B | $46.9B |
| Cash and short-term investments | $9.94B | $9.56B | $9.48B | $8.25B | $7.21B |
Income statement
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue | $87B | $84.3B | $84B | $82B | $80.2B |
| Cost of revenue | $43.4B | $41.2B | $40.8B | $42.8B | $42.2B |
| Gross profit | $43.7B | $43.1B | $43.2B | $39.2B | $38B |
| Research and development expenses | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Selling, general and administrative expenses | $23.9B | $22.7B | $23.3B | $21.1B | $20.2B |
| Other expenses | $0.00 | $0.00 | $1.34B | $0.00 | $0.00 |
| Operating expenses | $23.9B | $22.7B | $24.6B | $21.1B | $20.2B |
| Cost and expenses | $67.3B | $63.8B | $65.5B | $63.9B | $62.4B |
| Interest income | $430M | $469M | $473M | $307M | $51M |
| Interest expense | $877M | $907M | $925M | $756M | $439M |
| Depreciation and amortization | $0.00 | $2.85B | $2.9B | $2.71B | $2.81B |
| Ebitda | $21.3B | $23.9B | $22.6B | $21.8B | $21.2B |
| Operating income | $19.7B | $20.5B | $18.5B | $18.1B | $17.8B |
| Total other income/expenses, net | $629M | -$-284M | $216M | $219M | $182M |
| Income before tax | $20.4B | $20.2B | $18.8B | $18.4B | $18B |
| Income tax expense | $4.23B | $4.1B | $3.79B | $3.62B | $3.2B |
| Net income | $16B | $16B | $14.9B | $14.7B | $14.7B |
| Weighted average shares outstanding | $2.42B | $2.45B | $2.36B | $2.37B | $2.46B |
| Weighted average diluted shares outstanding | $2.42B | $2.45B | $2.47B | $2.48B | $2.54B |
Balance sheet
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $9.94B | $9.56B | $9.48B | $8.25B | $7.21B |
| Net receivables | $6.06B | $6.19B | $6.12B | $5.47B | $5.14B |
| Inventory | $8.17B | $7.55B | $7.02B | $7.07B | $6.92B |
| Total current assets | $26.2B | $25.4B | $24.7B | $22.6B | $21.7B |
| Property, plant and equipment, net | $25.4B | $23.9B | $22.2B | $21.9B | $21.2B |
| Goodwill and intangible assets | $62.7B | $63.6B | $62.4B | $64.4B | $63.4B |
| Long-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $140M |
| Total non-current assets | $100.3B | $99.8B | $97.7B | $98.2B | $95.6B |
| Total assets | $126.5B | $125.2B | $122.4B | $120.8B | $117.2B |
| Accounts payable | $16.3B | $15.2B | $15.4B | $14.6B | $14.9B |
| Short-term debt | $11.5B | $9.77B | $7.43B | $10.5B | $8.85B |
| Deferred revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total current liabilities | $38.7B | $36.1B | $33.6B | $35.8B | $33.1B |
| Long-term debt | $23.5B | $25.7B | $25.9B | $25B | $23.4B |
| Deferred revenue, non-current | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current liabilities | $33.5B | $36.9B | $38.2B | $38B | $37.3B |
| Capital lease obligations | $887M | $956M | $909M | $817M | $800M |
| Total liabilities | $72.2B | $72.9B | $71.8B | $73.8B | $70.4B |
| Common stock | $4.01B | $4.01B | $4.01B | $4.01B | $4.01B |
| Retained earnings | $135.9B | $130B | $123.8B | $118.2B | $112.4B |
| Accumulated other comprehensive income (loss) | -$-12.47B | -$-12.14B | -$-11.9B | -$-12.22B | -$-12.19B |
| Total equity | $54.5B | $52.3B | $50.6B | $47.1B | $46.9B |
| Total investments | $0.00 | $0.00 | $0.00 | $0.00 | $140M |
| Total debt | $35B | $35.5B | $33.4B | $35.4B | $32.3B |
| Net debt | $25.1B | $25.9B | $23.9B | $27.2B | $25.1B |
Cash flow statement
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Net income | $16.1B | $16.1B | $14.9B | $14.7B | $14.8B |
| Depreciation and amortization | $3.16B | $2.85B | $2.9B | $2.71B | $2.81B |
| Stock-based compensation | $524M | $476M | $562M | $545M | $528M |
| Change in working capital | $2M | -$-2.47B | -$-436M | -$-1.22B | -$-1.15B |
| Accounts receivable | $84M | $45M | -$-766M | -$-307M | -$-694M |
| Inventory | -$-641M | -$-324M | -$-70M | -$-119M | -$-1.25B |
| Accounts payable | $919M | -$-542M | $1.81B | $313M | $1.43B |
| Net cash provided by operating activities | $20.3B | $17.8B | $19.8B | $16.8B | $16.7B |
| Investments in property, plant and equipment | -$-4.41B | -$-3.77B | -$-3.32B | -$-3.06B | -$-3.16B |
| Acquisitions, net | -$-77M | -$-11M | -$-21M | -$-765M | -$-1.38B |
| Net cash used for investing activities | -$-4.62B | -$-3.82B | -$-3.5B | -$-3.5B | -$-4.42B |
| Common stock issued | $798M | $1.71B | $0.00 | $0.00 | $0.00 |
| Common stock repurchased | -$-5.03B | -$-6.5B | -$-5.01B | -$-7.35B | -$-10B |
| Dividends paid | -$-10.23B | -$-9.87B | -$-9.31B | -$-9B | -$-8.77B |
| Net cash used for financing activities | -$-15.2B | -$-14.04B | -$-14.86B | -$-12.15B | -$-14.88B |
| Net change in cash | $412M | $74M | $1.24B | $1.03B | -$-3.07B |
| Cash at end of period | $9.97B | $9.56B | $9.48B | $8.25B | $7.21B |
| Operating cash flow | $20.3B | $17.8B | $19.8B | $16.8B | $16.7B |
| Capital expenditure | -$-4.41B | -$-3.77B | -$-3.32B | -$-3.06B | -$-3.16B |
| Free cash flow | $15.9B | $14B | $16.5B | $13.8B | $13.6B |
Line items
Line items
Line items
About The Procter & Gamble Company
The Procter & Gamble Company, commonly referred to as P&G, is a global enterprise that supplies a broad spectrum of branded consumer products to markets worldwide. The company's operations are divided into five main business divisions: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers an assortment of hair care products, including conditioners, shampoos, styling aids, and treatments, under popular names like Head & Shoulders, Herbal Essences, Pantene, and Rejoice. It also features antiperspirants, deodorants, personal cleansing solutions, and skin care items from brands such as Olay, Old Spice, Safeguard, Secret, and SK-II. Within the Grooming division, P&G provides a range of shave care products and grooming appliances, prominently featuring brands like Braun, Gillette, and Venus. The Health Care unit encompasses oral hygiene essentials, including toothbrushes, toothpastes, and other dental care products sold under the Crest and Oral-B brand names. This segment further extends to gastrointestinal remedies, rapid diagnostics, respiratory care, vitamins/minerals/supplements, pain relief, and various other personal health care items from brands such as Metamucil, Neurobion, Pepto-Bismol, and Vicks. In the Fabric & Home Care category, consumers find fabric enhancers, laundry additives, and laundry detergents through labels like Ariel, Downy, Gain, and Tide. Additionally, this division offers air care products, dishwashing solutions, professional cleaning supplies (P&G Professional), and surface cleaners, exemplified by brands such as Cascade, Dawn, Fairy, Febreze, Mr. Clean, and Swiffer. Finally, the Baby, Feminine & Family Care segment provides infant care products, including baby wipes, taped diapers, and pants, under the Luvs and Pampers brands. It also supplies adult incontinence and feminine hygiene products from Always, Always Discreet, and Tampax, along with paper towels, tissues, and toilet paper marketed as Bounty, Charmin, and Puffs. P&G distributes its extensive product portfolio through a vast commercial network, including large retail chains, e-commerce platforms, grocery stores, membership clubs, pharmacies, department stores, various distributors, wholesalers, specialty beauty retailers, high-frequency stores, electronics outlets, and professional channels, as well as direct-to-consumer sales. The Procter & Gamble Company was established in 1837 and its corporate headquarters are located in Cincinnati, Ohio.
- CEO
- Shailesh G. Jejurikar
- Employees
- 109K
- Beta
- 0.38
Included in
Explore
Frequently asked questions
What is the intrinsic value of The Procter & Gamble Company (PG)?
The Procter & Gamble Company (PG) is currently overvalued based on the InvestorsCraft IC model — IC value is 20–50% below the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.
Is PG undervalued?
PG trades at a price of $169.37 (Nov 21, 2026): overvalued — IC value is 20–50% below the price.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.